| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.084 | 0.1 |